Investors

Reconciliation of Share Capital Audit Q4 FY 2024-25
Disclosure under Reg. 74(5) of SEBI (DP) Regulations - Q4 FY 2024-25
SDD Compliance Certificate for Q4 FY 2024-25
Disclosure u/r. 31(4) of SEBI SAST

Allotment of Equity Shares by Shalby Medtech Ltd to Shalby Ltd
Termination Franchise Agreement Ranchi
Closure of Trading Window - Q4 FY 2024-25
Credit Rating
Receipt of Hand Transplant Approval
Postal Ballot Notice
Demand Order by Office of Goods and Service Tax & Central Excise
Audio Recording of Earnings Call-05-02-2025
Grant of ESOP under Shalby Limited Employee Stock Options Scheme- 2021
Integrated Filing - Financials for Q3 FY 2024-25
Re-appointment of Dr. Vikram Shah as Chairman and Managing Director
Schedule of Earning Conference call to discuss Q3FY25 earnings on 5th February 2025 at 2:30 pm. IST
Inauguration of Shalby Tissue & Bone Bank at Krishna Shalby Hospital, Ahmedabad
Shalby Advanced Technologies (SAT) Inc., USA received US FDA approval for its Product
Reconciliation of Share Capital Audit for Q3 FY 2024-25
Disclosure under Reg. 74(5) of SEBI (DP) Regulations - Q3 FY 2025
Closure of Trading Window - Q3 FY 2024-25
Exercise of 1000 Stock Options under Shalby Limited Employees Stock Option Scheme – 2021
Disclosure under regulation 29(2) of SEBI (SAST) Regulations, 2011
Disclosure under regulation 7(2) of SEBI (PIT) Regulations, 2015
Exercise of 3000 Stock Options under Shalby Limited Employee Stock Option Scheme – 2021
Audio Recording of Conference Call - 30-10-2024
Schedule of Earning Conference call to discuss Q2FY25 earnings on 30th October 2024 at 5:30 pm. IST
Resignation of Chief Marketing Officer
Reconciliation of Share Capital Audit for Q2 FY 2024-25
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 - Q2 FY 2025
Shalby Sanar International Hospitals honored with AACI International Accreditation
Receipt of Prestigious Award “Best Hospital Chain of the Year (West)
Outcome of 20th Annual General Meeting of the Company
Closure of Trading Window - Q2 FY 2024-25
Receipt of Bone Bank License
Business Responsibility and Sustainability Report (BRSR)
Notice of 20th Annual General Meeting
Newspaper Advertisement for AGM
Resignation of Senior Management Personnel
Appointment of Chief Marketing Officer
Grant of 60,000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
Exercise of 2000 Stock Options under Shalby Limited Employee Stock Option Scheme – 2021
Availing Term Loan of Rs. 600 million from HDFC Bank Ltd.
Inauguration of Shalby Orthopedic Center of Excellence at Rajkot
Exercise of 4000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
Grant of 85,500 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
Exercise of 2000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
Grant of 40,000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
Receipt of order of Hon’ble Charity Commissioner, Maharashtra State, Mumbai
Reconciliation of Share Capital Audit for Q1 FY 2024-25
Audio Recording of Conference Call - 09-07-2024
Re‐appointment of Mr. Shanay Shah, to hold office or place of profit
Change in mode of Investor Conference Call scheduled on July 9, 2024.
Certificate UR 74(5) of SEBI (DP) Regulations, 2018 - Q1 FY 2025
Schedule of Investor Conference Call to discuss Q1 FY 2024-25 results – 9th July 2024
Closure of Trading Window for Q1 FY 2024-25
Termination of Franchise Agreement with Madhuban Orthopedic and Multispecialty Surgical Hospital Private Limited, Udaipur
Availing SBLC & Working Capital Facilities from Citibank N.A.
Exercise of 3000 Stock Options under Shalby Limited Employees Stock Options Scheme – 2021
Exercise of 5,000 Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
Audio Recording of Investors Conference Call – 29-05-2024
Declaration pursuant to Regulation 33(3 (d) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Recommendation of Dividend for the financial year 2023‐2024
Intimation of Grant of Options under Shalby Limited Employees Stock Options Scheme – 2021
Schedule of Investor Conference Call to discuss Q4 FY 2023-24 results – 29th May 2024
Issuance of Corporate Guarantee for credit facilities amounting to Rs. 42 crore granted to Mars Medical Devices Limited (wholly‐owned subsidiary company)
Allotment by SAT India to SAT Inc, USA
Exercise of Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
Annual Secretarial Compliance Report FY 2023-24
Issuance of Corporate Guarantee amounting to Rs. 55.85 crore for Credit facilities granted to PK Healthcare Pvt. Ltd. (Subsidiary Company)
Availing credit facilities from IndusInd Bank Ltd

Certificate ur. 7(3) - FY 2024
Certificate ur. 74(5) - Q4 FY 2024
Certificate under 40(10)
Reconciliation of Share Capital Audit Report Q4 FY 2023-24
Completion of Acquisition of 100% Equity Stake in Healers Hospital Pvt. Ltd
Availing Term Loan of Rs. 100 crore from Bajaj Finance Ltd for acquisition of 100% stake in Healers Hospital
Acquisition of 100% equity stake in Healers Hospital Pvt. Ltd.
Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015 – 07-03-2024
Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011 – 07-03-2024
Notice to MMDL from Customs Dept
Recording of Conference call – 12-02-2024
Grant of ESOP
Concall Invite Q3 FY 2023-24
Change in Senior Management - Resignation of Chief Business Officer
Closure of Corporate Guarantee
PK Healthcare Pvt. Ltd. become subsidiary of Shalby Ltd.
Exercise of Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
Acquisition of 87.26% stake in PK Healthcare Pvt. Ltd. (Sanar International Hospitals)
Dr. Vikram Shah, CMD awarded with Prestigious Healthcare Entrepreneur Award by Hurun
Shalby Academy – Signing of MoU with Kaushalya, Skill University of the Government of Gujarat, at Vibrant Gujarat Global Summit 2024
Appointment of Global Chief Business Officer
Reaffirmation and Assignment of Credit Rating
Reconciliation of Share Capital Audit Report Q3 FY 2023-24
Certificate ur. 74(5) – Q3 FY 2023-24
Closure of Trading Window for Q3 FY 2023-24
Further Investment by MMDL in SGTPL (December 2023)
Availing enhanced SBLC facilities
Investor Meet on 06-12-2023
Exercise of Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
Investor Meet 05-12-2023 at Singapore
Participating in Road Show at Singapore on 04-12-2023
Intimation of Change in Senior Management
Execution of Amendment Agreement with BCJ Hospital (Santacruz)
Recording of Conference call – 30-10-2023
Healthcare Personality of the Year Award 2023 (FICCI) to Our CMD, Dr. Vikram Shah
Grant of ESOP
Concall Invite Q2 FY 2023-24
Update On Pending Material Litigation - Order Passed By Statutory Authority
Reconciliation of Share Capital Audit Report Q2 FY 2023-24
Certificate ur. 74(5) – Q2 FY 2023-24
Intimation to investors on Online Dispute Resolution (ODR) Mechanism
Closure of Trading Window for Q2 FY 2023-24
Further Investment by MMDL in SGTPL (Sept 2023)
Allotment of Preference Shares by MMDL to Shalby
Analyst Meet with New Varnon Capital
Signing of MoU with Sardar Vallabhbhai Global University by Shalby Academy (a Unit of Shalby Ltd.)
Investment by Mars Medical Devices Limited in its subsidiary (SAT) by way of Preference Stock
Secretarial Compliance
Clarification to NSE for delay in disclosure of Transcript of Earning Conference Call
Clarification to NSE for spurt in volume
Clarification to BSE for spurt in volume
Agreement for SOCE-Ranchi
Participation in Conference call – IIFL Securities
Closure of Trading Window for Q1 FY 2023-24
Certificate ur. 74(5) – Q1 FY 2023-24
Reconciliation of Share Capital Audit Report Q1 FY 2023-24
Grant of ESOP
Concall Invite Q1 FY 2023-24
Clarification to NSE regarding Corporate Governance Report Q1 FY2023-24
Clarification to BSE regarding Shareholding Pattern Q1 FY2023-24
Analyst Meet with Motilal Oswal Asset Management
Inauguration of Hospital at Ranchi
Disclosure - Details of Pending Material Litigation(s) / Disputes
Clarification to BSE regarding Corporate Governance Report Q1 FY2023-24
Investor / Analyst Meet – 05-09-2023
Clarification to NSE for spurt in volume
Signing of MoU with P P Savani University by Shalby Academy
Intimation to Shareholders for updation of KYC/PAN/Nomination
Initial disclosure on large corporates
Reappointment of Auditors for Second term
Disclosure u/r. 30(5) of SEBI LODR for determining criteria & Disclosure of materiality of events
Change in KMP
Appointment of Independent Director
Dividend announcement

Concall Invite Q4 FY 2022-23
concall recording Q4 FY2022-23
Concall Invite Q4 FY2023
Outcome of Board Meeting for year ended March 31, 2023
Certificate under 40(10)
Reconciliation of Share Capital Audit Report Q4 FY 2022-23
Certificate ur. 74(5) – Q4 FY 2023
Certificate ur. 7(3) - FY 2023
Closure of Trading Window for Q4 FY 2022-23
Allotment of Preference Shares to Shalby Ltd by Mars Medical Devices Limited
Further Investment by MMDL in SGTPL (Mar 2023)
Signing of MOU with Silver Oak University by Shalby Academy.
Schedule of Investor Meet (Feb 2023)
Receipt of Import License by Step-down subsidiary – Shalby Global Technologies Pte. Ltd., Singapore
Signing of MOU with IIPH Gandhinagar by Shalby Academy
Schedule of Investor / Analyst meet
Update On Vrundavan Shalby Hospitals Limited - Wholly Owned Subsidiary
Inauguration of Shalby Orthopedics Centre of Excellence (SOCE) at Gwalior
Reconciliation of Share Capital Audit report Q3 FY 2022-23.
93ScheduleConcall as Concall Invite Q3 FY 2023
94Reg745 as Certificate ur. 74(5) – Q3 FY 2023
Closure of Trading Window for Q3 FY2023
Allotment to Shalby Ltd by Vrundavan Shalby Hospitals Ltd.
Reaffirmation of Credit Rating
Conversion of Loan of MMDL to SAT into Preferred Stock and Common Stock
Schedule of Investor Meet (Dec 2022)
Shalby Issued SBLC Amounting To USD 9.45 Million For Shalby Advanced Technologies
Disclosure under Reg 29(2) of SEBI (SAST) Reg
Disclosure under Reg 29(2) of SEBI (SAST) Reg
Disclosure under Reg 29(2) of SEBI (SAST) Reg
Demise of Mr. Kiritbhai Chimanlal Shah, Promoter Group
Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011 – 29-11-2022
Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015 – 29-11-2022
Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011 – 17-11-2022
Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015 – 17-11-2022
Grant of ESOPs
Newspaper Ad – Postal Ballot 2022
Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015
Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011
Appointment of Mr. Parag Agarawal as Chief Business Officer
Calendar of Events for Postal Ballot Process.
Newspaper Advertisement for Q2 FY2023 Results
Initial Disclosure under SEBI(PIT) Reg, by Mr. Vijay Kedia, director
Appointment of Mr. Vijay Kedia as Additional Director (Non-Executive Non Independent).
Re-appointment of Mrs. Sujana Shah as an Independent Director for second term w.e.f. 7th May 2023.
Reconciliation of Share Capital Audit report
Grant of Options under ESOP Scheme 2021 (Oct 2022)
Concall Invite Q2 FY 2023
Certificate ur. 74(5) – Q2 FY 2023
Allotment of Equity & Preference Shares by MMDL to Shalby
Closure of Trading Window Q2 FY2023
Further Investment by MMDL in SGTPL (Aug 2022)
Terms of Grant of Options
Shalby Enters into Partnership with Australian Health Ed-Tech Company
Concall Invite Q1 FY 2023
Reconciliation of Share Capital Audit Report Q1 FY 2023
Certificate ur. 74(5) – Q1 FY 2023
Grant of Options under ESOP Scheme 2021 (Jul 2022)
Disclosure under SEBI (SAST) Regulations, 2011 (14 Jun 2022)
SEBI (Prohibition of Insider Trading) Reg.2015 (14 Jun 2022)
Grant of Options under ESOP Scheme 2021 (Jun 2022)
Disclosure under SEBI (SAST) Regulations, 2011 (Jun 2022)
SEBI (Prohibition of Insider Trading) Reg. 2015 (Jun 2022)
Annual Secretarial Compliance Report FY2021-22
Acq. of Shares by Shalby Employees Welfare Trust (May 2022)
Grant of Options Under ESOP Scheme 2021 (May 2022)

Concall Invite Q4 FY2022
Newspaper Advertisement for Q4 FY2022 Results
Certificate under Reg. 40(10) of SEBI (LODR) – FY 2022
Disclosure of Large Corporate (Apr 2022)
Reconciliation of Share Capital Audit Report Q4 FY 2022
Certificate ur. 74(5) – Q4 FY 2022
Certificate ur. 7(3) - FY 2022
Further Investment by MMDL in SGTPL (Mar 2022)
Change in Name of Registrar & Transfer Agent (Mar 2022)
Schedule of Investor-Analyst Meet (Mar 2022)
Schedule of Group Investor-Analyst Meet (Mar 2022)
Inauguration of SOCE in Ahmedabad (Mar 2022)
Receipt of Import License to Subsidiary - MMDL (Feb 2022)
Schedule of Investor-Analyst Meet Q3 FY2022
Determining Materiality of an Event/Info by KMPs(Feb 2022)
Appointment of Chief Financial Officer (Feb 2022)
Further Investment by MMDL in SAT (Jan 2022)
Certificate Under Reg. 74(5) Q3 FY 2022
Reconciliation of Share Capital Audit Report Q3 FY 2022
Resignation of Chief Financial Officer (Dec 2021)
Further investment by MMDL in SGTPL (Dec 2021)
Schedule of Investor-Analyst Meet (Nov 2021)
Long Term Credit Rating for Enhanced Rated Amount (Nov 2021)
Newspaper Advertisement for Q2 FY2022 Results
Schedule of Investor-Analyst Meet Q2 FY2022
Reconciliation of Share Capital Audit Report Q2 FY2022
Upgradation of Credit Rating (Sep 2021)
Revised Conference Call Invite (Aug 2021)
Conference Call Invite (Aug 2021)
Mars Medical Acquires 96% Shares in Shalby Global (Jul 2021)
Reconciliation of Share Capital Audit Report Q1 FY2022
Certificate Under Reg. 74(5) (Jun 2021)
Reg. 30 of SEBl (LODR)- Inaugurated Shalby Zynova (Jun 2021)
Annual Secretarial Compliance FY 2020-21
Conference Call Invite & Investor Presentation (May 2021)
Appointment of Vice Chairman & Global President (May 2021)
Concall Invite for Audited Financials-Q4 & FY2021 (May 2021)
Step-down Subsidiary in USA (May 2021)
Newspaper Publication - Offer for Sale (Apr 2021)
Disclosure of Large Corporate (Apr 2021)

Intimation Of Subsidiary Company
Con-call with Investors to address general queries about ongoing COVID-19 pandamic
Con-call with Investors hosted by HDFS Sec to address general queries about ongoing COVID-19 pandemic
Clarification Of Price MOvement To NSE
Clarification Of Price MOvement To BSE
Intimation of Testing of COVID-19 cases at Indore Shalby Hospital
Con-call intimation hosted by Edelweiss
Con-call intimation hosted by Edelweiss
Compliance Certificate 7(3) – 31-03-2020
Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018
Treatment of Covid-19 Patient at Shalby Hospital
Conference call hosted by Centrum Broking Ltd.
Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20
Reconciliation of Share Capital Audit Report Q4 FY 2019-20
Disclosure as to Large Corporate
Schedule of Investor / Analyst Meet Q4 FY20
Trading Window Closure Notice For Q1 FY2021
Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Surat
Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Vapi
Credit Rating ICRA Reg 30 LODR
Certificate under Regulation 74 (5) Q1 2020-21
Disclosure of impact of CoVID-19 on the business and operations
Reconciliation of Share Capital Audit Report Q1 FY 2020-21
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome”
Announcement under Secretarial Compliance Report FY 2019-20”
Aquisition Subsidiaries
Investor Call Intimation
Submission of newspaper ad for results Q1 FY2020-21
Notice of 16th Annual General Meeting
Intimation of Board of Directors Meeting
Outcome of Board meeting
Compliance Certificate 7(3) – 30-09-2020
Certificate under Regulation 74 (5) Q2 2020-21
Investor Conference Call Q2 F.Y. 2020-21
Newspaper Ad for Results Q2 FY 2020-21
Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2020-21
Reconciliation of Share Capital Audit Report Q2 FY 2020-21
Investor Analyst Call
Intimation Of Subsidiary Company SHMPL
Trading Window Closure
Certificate under Regulation 74 (5) Q3 2020-21
Schedule of Investor / Analyst Meet Q3 FY2021
Shalby Limited Q3 FY2021 Press Release
Reconciliation of Share Capital Audit Report Q3 FY 2020-21
Investor / Analyst Meet
Change in Company Secretary & Compliance Officer
Disclosure under Regulation 30 (5) of the SEBl - LODR
Annual Secretarial Compliance Report FY2021
Reconciliation of Share Capital Audit Report Q4 FY2021

Intimation of Trading Window Closure
Compliance Certificate 7(3)-31-03-2019
Intimation Of Analyst Meet
Certificate under Regulation 40(10) of SEBI LODR –H2 FY 2018-19
Reconciliation of Share Capital Q4 2018-19
Interaction with electronic media
Recommendation of Dividend for FY 2018-19
Schedule of Investor / Analyst Meet Q4 FY19
Submission of newspaper ad results Q4 FY2018-19
Disclosure under SEBI PIT Reg. 7(2) 30.05.2019
Disclosure under SEBI PIT Reg. 7(2) 01.06.2019
Annual Secretarial Compliance Report FY 2018-19
Intimation of Trading Window Closure
Best IT enabled Hospital Award
Reconciliation of Share Capital Q1 2019-20
Certificate under Regulation 74 (5) Q1 2019-20
Schedule of Investor Conference Call Q1 FY19
News Paper Advertisement PAS-1 AGM
Participation in Emkay Confluence at Mumbai – 08-Aug-2019
Participation in Elara Annual Conference at Mumbai-– 05-September-2019
Gujarat HealthCare Leadership Award 2019
Intimation of Trading Window closure – Q2 FY 2019-20 Fin. Results
Dare to Dream -Zee Business Award - Company of the Year
Credit Rating ICRA Reg 30 LODR
Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20
Clarification Of Price Movement
Investor Con-call Q2 FY2019-20
Press Release- Q2FY20 Financial Results
Submission of newspaper ad results Q2 FY2019-20
Change of name of Registrar & Transfer Agent
Intimation of Trading Window closure – Q3 FY 2019-20 Fin. Results
Compliance Certificate Q3 30-09-2019
Reconciliation of Share Capital Audit Report Q3 FY 2019-20
Change in Details of RTA
Investor Con-call Q3 FY2019-20
Clarification as to increase in volume of shares
Re-appointment of CMD
Submission of newspaper ad results Q3 FY2019-20
Disclosure under SEBI PIT Reg. 7(2) 26.02.2020

Statement of Investor Complaints – Q4 FY 2017-18
Share Capital Audit – 31-03-2018
Compliance Certificate under Reg. 7(3) of LODR
Press Release – MoU with Sen Sok Intl Hospital, Cambodia
Certificate under Regulation 40(10) of SEBI LODR
Joint Replacement Surgeries under Mukhyamantri Amrutam Yojana
Change in CIN
Schedule of Investor / Analyst Meet
Schedule of Investor / Analyst Meet – 27-04-2018
Intimation Conference Call
Intimation Appointment of CDSL as designated depository
Collaboration with Berkeley Health Education
Investor/Analyst meeting with Motilal Oswal Securities Limited
Investors meet/UBS India- Midcap conference
Resignation of Chief Executive Officer of the Company
Intimation Analyst meet HDFC Securities 26-06-2018
Updates relating to resignation of CEO
Man of the Year Award – Dr. Vikram Shah
Intimation Analyst meet – 26-06-2018
Intimation Analyst meet - 27-06-2018
Intimation Analyst meet - 02-07-2018
Intimation Analyst meet – 06-07-2018
Intimation Liver Disease and Transplantation
Karvy Reconciliation Report
Investor Grievance report
Intimation of AGM
Intimation of Book closure
AGM Notice & Annual Report 2017-18
Newspaper Ad. AGM, Book closure & E-voting
Outcome of AGM
Voting Results
Shalby Press Release - Ovarian Mass Removal Jaipur
Credit Rating ICRA Reg 30 LODR
Reg 30 Orthotrends 2018 Chandigarh
Intimation under Regulation 30 of SEBI LODR-concall with Edelweiss
Investor Grievance Report Q2 FY 2018-19
Share Capital Audit Q2 FY 2018-19
Compliance Certificate 7(3) – 30-09-2018
Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2018-19
Pre Accreditation Entry level NABH at Shalby Surat
Intimation for Conference call
Submission of newspaper AD – Notice of Board Meeting
Pre-Accreditation Entry level NABH at Shalby Naroda
Newspaper ad for Issue of Duplicate Shares
Intimation Analyst Meet – Nalanda Capital
Intimation participation in IDFC Investor Conference
Investor conference Kotak
Intimation Issue of Duplicate Shares
Press Release Kolkata
Intimation Transfer of operations Karvy
Medical Value Travel Specialist Hospital Award 2018
Best hospital for Medical Tourism in Gujarat Award
Share Capital Audit Q3 FY 2018-19
Intimation of Investor Analyst Concall
Intimation of Conference Call
Intimation Analyst meet - DSP BlackRock Investment
Newspaper ad for Q3 FY 2018-19 Results

Disclosure under SEBI PIT Reg. 7(2)
Announcement - Dr. Purvish Parikh as -Group Advisor
Press Release - Radiation Therapy Centre, Jaipur
Press Release - Radiation Therapy Centre, Naroda, Ahmedabad
Authorization to KMP under Reg. 30 of SEBI LODR
Statement of Investors Complaints – Q3 FY 2017-18
Disclosure under SEBI PIT Reg. 7(2)
Intimation about Loss of Share certificates
Press Release – MoU with with Gleneagles Global Health City for Heart & Lung Transplants Program